Home
>
US Stocks
>
Homology Medicines Inc
Homology Medicines Inc
FIXX

Homology Medicines Inc (FIXX)

$6.0113.65%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.95
Today Low/High
5.8 / 6.08
52 Week Low/High
$5.94 / $15.24
Market Cap
$373.36M

Company Details

Homology Medicines, Inc. is a clinical-stage genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology's proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its family of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
Organisation
Homology Medicines Inc
Headquaters
Bedford, Massachusetts, US
Employees
205
Industry
Health Technology
CEO
Arthur Tzianabos

Discover more

Frequently Asked Questions

What is Homology Medicines Inc (FIXX) share price today?

Can Indians buy Homology Medicines Inc (FIXX) shares?

How can I buy Homology Medicines Inc (FIXX) shares from India?

Can Fractional shares of Homology Medicines Inc (FIXX) be purchased?

What are the documents required to start investing in Homology Medicines Inc (FIXX) stocks?

We are a SEBI registered investement advisor